(-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of SMO mRNA], epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of SMO protein] CTD PMID:27058323 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SMO mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SMO mRNA CTD PMID:17586704 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SMO mRNA CTD PMID:21570461 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:3726 6480464 Tetrachlorodibenzodioxin affects the expression of SMO mRNA CTD PMID:22298810 2-acetamidofluorene increases expression ISO RGD:3726 6480464 2-Acetylaminofluorene results in increased expression of SMO mRNA CTD PMID:17187413 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of SMO mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO RGD:733306 6480464 Fluorouracil results in decreased expression of SMO mRNA, Fluorouracil results in decreased expression of SMO protein CTD PMID:18776995 , PMID:25190613 aflatoxin B1 increases expression ISO RGD:3726 6480464 Aflatoxin B1 results in increased expression of SMO mRNA CTD PMID:25378103 aldehydo-D-glucose multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein more ... CTD PMID:27481074 ammonium chloride affects expression ISO RGD:3726 6480464 Ammonium Chloride affects the expression of SMO mRNA CTD PMID:16483693 arsenous acid decreases activity ISO RGD:733306 6480464 Arsenic Trioxide results in decreased activity of SMO protein mutant form CTD PMID:24859340 benzo[a]pyrene decreases expression ISO RGD:733306 6480464 Benzoapyrene results in decreased expression of SMO mRNA CTD PMID:26238291 benzo[a]pyrene decreases methylation ISO RGD:733306 6480464 Benzoapyrene results in decreased methylation of SMO promoter CTD PMID:27901495 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:3726 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SMO promoter CTD PMID:23359474 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of SMO mRNA CTD PMID:28123099 bisphenol A multiple interactions ISO RGD:3726 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SMO promoter CTD PMID:23359474 bisphenol A affects expression ISO RGD:733306 6480464 bisphenol A affects the expression of SMO mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:3726 6480464 bisphenol A results in decreased expression of SMO mRNA CTD PMID:25181051 calciol increases expression EXP 6480464 Cholecalciferol results in increased expression of SMO mRNA CTD PMID:17170073 captopril multiple interactions ISO RGD:3726 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of SMO protein], Captopril inhibits the reaction [Silicon Dioxide results in increased expression of SMO protein] CTD PMID:31181250 captopril multiple interactions ISO RGD:733306 6480464 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of SMO protein] CTD PMID:31181250 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of SMO mRNA CTD PMID:25554681 carboplatin increases expression ISO RGD:733306 6480464 Carboplatin results in increased expression of SMO mRNA CTD PMID:25605917 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SMO gene CTD PMID:20938992 chromium(6+) multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of SMO mRNA more ... CTD PMID:31756458 cisplatin multiple interactions ISO RGD:733306 6480464 Cisplatin promotes the reaction [jinfukang results in increased expression of SMO mRNA], jinfukang promotes the reaction [Cisplatin results in increased expression of SMO mRNA] CTD PMID:27392435 cisplatin increases expression ISO RGD:733306 6480464 Cisplatin results in increased expression of SMO mRNA CTD PMID:27392435 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SMO mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SMO mRNA] CTD PMID:17585979 colforsin daropate hydrochloride multiple interactions ISO RGD:3726 6480464 Colforsin inhibits the reaction [Carbon Tetrachloride results in increased expression of SMO mRNA] CTD PMID:27590029 copper(II) sulfate decreases expression ISO RGD:733306 6480464 Copper Sulfate results in decreased expression of SMO mRNA CTD PMID:19549813 Cyclopamine increases expression ISO RGD:733306 6480464 cyclopamine results in increased expression of SMO mRNA CTD PMID:26710974 Cyclopamine multiple interactions EXP 6480464 cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein] CTD PMID:27481074 Cyclopamine multiple interactions ISO RGD:3726 6480464 cyclopamine inhibits the reaction [resveratrol results in increased expression of SMO protein] more ... CTD PMID:24388991 , PMID:24464877 Cyclopamine multiple interactions ISO RGD:733306 6480464 mono-2-ethylhexylphthalate inhibits the reaction [cyclopamine results in increased expression of SMO mRNA] CTD PMID:26710974 D-glucose multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein more ... CTD PMID:27481074 dexamethasone decreases expression ISO RGD:733306 6480464 Dexamethasone results in decreased expression of SMO mRNA CTD PMID:25047013 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SMO mRNA CTD PMID:29950665 diarsenic trioxide decreases activity ISO RGD:733306 6480464 Arsenic Trioxide results in decreased activity of SMO protein mutant form CTD PMID:24859340 dibutyl phthalate increases expression ISO RGD:3726 6480464 Dibutyl Phthalate results in increased expression of SMO mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions ISO RGD:3726 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SMO promoter CTD PMID:23359474 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of SMO mRNA CTD PMID:22467019 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein more ... CTD PMID:27481074 disodium selenite decreases expression ISO RGD:733306 6480464 Sodium Selenite results in decreased expression of SMO mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:733306 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of SMO mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:733306 6480464 Doxorubicin results in decreased expression of SMO mRNA CTD PMID:29803840 endosulfan decreases expression ISO RGD:3726 6480464 Endosulfan results in decreased expression of SMO mRNA CTD PMID:29391264 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid increases expression EXP 6480464 Folic Acid results in increased expression of SMO mRNA CTD PMID:25629700 gemcitabine increases expression ISO RGD:733306 6480464 gemcitabine results in increased expression of SMO mRNA CTD PMID:25605917 glucose multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein more ... CTD PMID:27481074 hydralazine multiple interactions ISO RGD:733306 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SMO mRNA CTD PMID:17183730 hydrogen peroxide increases expression ISO RGD:3726 6480464 Hydrogen Peroxide results in increased expression of SMO mRNA, Hydrogen Peroxide results in increased expression of SMO protein CTD PMID:31326407 hydrogen peroxide multiple interactions ISO RGD:3726 6480464 hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO mRNA], hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO protein] CTD PMID:31326407 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SMO gene CTD PMID:20938992 leflunomide decreases expression ISO RGD:733306 6480464 leflunomide results in decreased expression of SMO mRNA CTD PMID:28988120 menadione affects expression ISO RGD:733306 6480464 Vitamin K 3 affects the expression of SMO mRNA CTD PMID:20044591 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of SMO mRNA CTD PMID:18502557 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:733306 6480464 [mono-2-ethylhexylphthalate co-treated with Androgens deficiency] results in increased expression of SMO mRNA, mono-2-ethylhexylphthalate inhibits the reaction [cyclopamine results in increased expression of SMO mRNA] CTD PMID:26710974 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of SMO gene CTD PMID:15755804 , PMID:16724327 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of SMO mRNA, Diethylnitrosamine results in increased expression of SMO protein CTD PMID:27058323 N-nitrosodiethylamine multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of SMO mRNA] more ... CTD PMID:27058323 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SMO mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SMO mRNA] CTD PMID:17585979 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SMO mRNA CTD PMID:17562736 paraquat multiple interactions EXP 6480464 tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of SMO mRNA], tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of SMO protein] CTD PMID:30744607 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SMO mRNA, Paraquat results in increased expression of SMO protein CTD PMID:30744607 phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SMO mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:733306 6480464 Phenobarbital affects the expression of SMO mRNA CTD PMID:19159669 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of SMO mRNA CTD PMID:19482888 piperonyl butoxide multiple interactions EXP 6480464 Piperonyl Butoxide inhibits the reaction [SMO protein results in increased expression of GLI1 protein] CTD PMID:31642701 pirinixic acid multiple interactions EXP 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of SMO mRNA] CTD PMID:17950772 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SMO mRNA CTD PMID:17950772 , PMID:23811191 potassium chromate increases expression ISO RGD:733306 6480464 potassium chromateVI results in increased expression of SMO mRNA CTD PMID:22714537 potassium dichromate multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of SMO mRNA more ... CTD PMID:31756458 quercetin 3-O-beta-D-galactopyranoside multiple interactions ISO RGD:3726 6480464 hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO mRNA], hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO protein] CTD PMID:31326407 quercetin 3-O-beta-D-galactopyranoside increases expression ISO RGD:3726 6480464 hyperoside results in increased expression of SMO mRNA, hyperoside results in increased expression of SMO protein CTD PMID:31326407 resveratrol decreases expression ISO RGD:733306 6480464 resveratrol results in decreased expression of SMO more ... CTD PMID:22301921 more ... resveratrol multiple interactions ISO RGD:3726 6480464 cyclopamine inhibits the reaction [resveratrol results in increased expression of SMO protein], resveratrol results in increased expression of and affects the localization of SMO protein CTD PMID:24464877 Salinomycin decreases expression ISO RGD:733306 6480464 salinomycin results in decreased expression of SMO mRNA, salinomycin results in decreased expression of SMO protein CTD PMID:25499043 , PMID:30273566 SB 431542 multiple interactions ISO RGD:733306 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of SMO mRNA CTD PMID:27188386 silicon dioxide multiple interactions ISO RGD:3726 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of SMO protein] more ... CTD PMID:31181250 silicon dioxide increases expression ISO RGD:3726 6480464 Silicon Dioxide results in increased expression of SMO protein CTD PMID:31181250 sodium fluoride increases expression ISO RGD:3726 6480464 Sodium Fluoride results in increased expression of SMO mRNA, Sodium Fluoride results in increased expression of SMO protein CTD PMID:24388991 sodium fluoride multiple interactions ISO RGD:3726 6480464 cyclopamine inhibits the reaction [Sodium Fluoride results in increased expression of SMO mRNA], cyclopamine inhibits the reaction [Sodium Fluoride results in increased expression of SMO protein] CTD PMID:24388991 sonidegib decreases response to substance EXP 6480464 SMO protein mutant form results in decreased susceptibility to sonidegib CTD PMID:24973920 sunitinib increases expression ISO RGD:733306 6480464 sunitinib results in increased expression of SMO mRNA CTD PMID:25605917 sunitinib decreases expression ISO RGD:733306 6480464 Sunitinib results in decreased expression of SMO mRNA CTD PMID:31533062 tetrachloromethane increases expression ISO RGD:3726 6480464 Carbon Tetrachloride results in increased expression of SMO mRNA CTD PMID:27590029 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SMO mRNA, Carbon Tetrachloride results in increased expression of SMO protein CTD PMID:31816328 tetrachloromethane multiple interactions EXP 6480464 GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of SMO mRNA], GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of SMO protein] CTD PMID:31816328 tetrachloromethane multiple interactions ISO RGD:3726 6480464 Colforsin inhibits the reaction [Carbon Tetrachloride results in increased expression of SMO mRNA] CTD PMID:27590029 tetramethylpyrazine multiple interactions EXP 6480464 tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of SMO mRNA], tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of SMO protein] CTD PMID:30744607 theaflavin multiple interactions EXP 6480464 theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of SMO mRNA], theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of SMO protein] CTD PMID:27058323 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SMO mRNA CTD PMID:29950665 valproic acid multiple interactions ISO RGD:733306 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SMO mRNA more ... CTD PMID:17183730 , PMID:27188386 valproic acid decreases expression ISO RGD:733306 6480464 Valproic Acid results in decreased expression of SMO mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:733306 6480464 Valproic Acid results in decreased methylation of SMO gene CTD PMID:29154799 valproic acid affects expression ISO RGD:733306 6480464 Valproic Acid affects the expression of SMO mRNA CTD PMID:25979313 vismodegib decreases expression ISO RGD:733306 6480464 HhAntag691 results in decreased expression of SMO mRNA CTD PMID:22087285 vismodegib decreases response to substance EXP 6480464 SMO protein mutant form results in decreased susceptibility to HhAntag691 CTD PMID:24973920 zinc atom increases expression ISO RGD:733306 6480464 Zinc results in increased expression of SMO mRNA CTD PMID:19071009 zinc(0) increases expression ISO RGD:733306 6480464 Zinc results in increased expression of SMO mRNA CTD PMID:19071009